These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15257175)

  • 1. CD14 C(-260)T gene polymorphism, circulating soluble CD14 levels and arteriosclerosis.
    Amar J; Ruidavets JB; Bal dit Sollier C; Bongard V; Boccalon H; Chamontin B; Drouet L; Ferrières J
    J Hypertens; 2004 Aug; 22(8):1523-8. PubMed ID: 15257175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble CD14 and aortic stiffness in a population-based study.
    Amar J; Ruidavets JB; Bal Dit Sollier C; Bongard V; Boccalon H; Chamontin B; Drouet L; Ferrières J
    J Hypertens; 2003 Oct; 21(10):1869-77. PubMed ID: 14508193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14.
    Karhukorpi J; Yan Y; Niemela S; Valtonen J; Koistinen P; Joensuu T; Saikku P; Karttunen R
    Clin Exp Immunol; 2002 May; 128(2):326-32. PubMed ID: 11985523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease.
    Koenig W; Khuseyinova N; Hoffmann MM; März W; Fröhlich M; Hoffmeister A; Brenner H; Rothenbacher D
    J Am Coll Cardiol; 2002 Jul; 40(1):34-42. PubMed ID: 12103253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter polymorphism in the endotoxin receptor (CD14) is associated with increased carotid atherosclerosis only in smokers: the Carotid Atherosclerosis Progression Study (CAPS).
    Risley P; Jerrard-Dunne P; Sitzer M; Buehler A; von Kegler S; Markus HS;
    Stroke; 2003 Mar; 34(3):600-4. PubMed ID: 12624278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter polymorphism of the gene for CD14 receptor is not associated with sub-clinical carotid atherosclerosis in a community population.
    Hung J; McQuillan BM; Chapman CM; Thompson PL; Beilby JP
    Eur J Cardiovasc Prev Rehabil; 2004 Aug; 11(4):344-9. PubMed ID: 15292769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity.
    Fernández-Real JM; Broch M; Richart C; Vendrell J; López-Bermejo A; Ricart W
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1780-4. PubMed ID: 12679473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of CD14 haplotypes and soluble CD14 on pulmonary function in agricultural workers.
    LeVan TD; Smith LM; Heires AJ; Mikuls TR; Meza JL; Weissenburger-Moser LA; Romberger DJ
    Respir Res; 2017 Mar; 18(1):49. PubMed ID: 28302109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR-4 and CD14 Genotypes and Soluble CD14: Could They Predispose to Coronary Atherosclerosis?
    Konstantinidou MK; Goutas N; Vlachodimitropoulos D; Chaidaroglou A; Stefanou D; Poumpouridou N; Mastorakou R; Gazouli M; Kyparissopoulos D; Spiliopoulou C
    J Cardiovasc Dev Dis; 2016 Mar; 3(1):. PubMed ID: 29367560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260T CD14 genotype are associated with severe acute pancreatitis.
    Rahman SH; Salter G; Holmfield JH; Larvin M; McMahon MJ
    Crit Care Med; 2004 Dec; 32(12):2457-63. PubMed ID: 15599151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD14 C260T promoter polymorphism and the risk of cerebrovascular diseases: a meta-analysis.
    Banerjee I
    J Appl Genet; 2009; 50(2):153-7. PubMed ID: 19433913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the CD14 C260T promoter polymorphism on C-reactive protein levels in patients with coronary artery disease.
    Bernardo E; Angiolillo DJ; Ramírez C; Cavallari U; Trabetti E; Sabaté M; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Pignatti PF; Macaya C; Fernandez-Ortiz A
    Am J Cardiol; 2006 Nov; 98(9):1182-4. PubMed ID: 17056323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter polymorphism in the CD14 gene and concentration of soluble CD14 in patients with in-stent restenosis after elective coronary stenting.
    Shimada K; Miyauchi K; Mokuno H; Watanabe Y; Iwama Y; Shigekiyo M; Matsumoto M; Okazaki S; Tanimoto K; Kurata T; Sato H; Daida H
    Int J Cardiol; 2004 Mar; 94(1):87-92. PubMed ID: 14996480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism in the promoter region of the insulin-like growth factor I gene is related to carotid intima-media thickness and aortic pulse wave velocity in subjects with hypertension.
    Schut AF; Janssen JA; Deinum J; Vergeer JM; Hofman A; Lamberts SW; Oostra BA; Pols HA; Witteman JC; van Duijn CM
    Stroke; 2003 Jul; 34(7):1623-7. PubMed ID: 12791939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The -159C/T polymorphism in the promoter region of the CD14 gene is associated with advanced liver disease and higher serum levels of acute-phase proteins in heavy drinkers.
    Campos J; Gonzalez-Quintela A; Quinteiro C; Gude F; Perez LF; Torre JA; Vidal C
    Alcohol Clin Exp Res; 2005 Jul; 29(7):1206-13. PubMed ID: 16046876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile.
    Unkelbach K; Gardemann A; Kostrzewa M; Philipp M; Tillmanns H; Haberbosch W
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):932-8. PubMed ID: 10195920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection.
    Meiler C; Muhlbauer M; Johann M; Hartmann A; Schnabl B; Wodarz N; Schmitz G; Scholmerich J; Hellerbrand C
    World J Gastroenterol; 2005 Oct; 11(38):6031-7. PubMed ID: 16273620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of circulating soluble CD14 in Kawasaki disease.
    Takeshita S; Nakatani K; Tsujimoto H; Kawamura Y; Kawase H; Sekine I
    Clin Exp Immunol; 2000 Feb; 119(2):376-81. PubMed ID: 10632678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis.
    Alavi-Naini R; Salimi S; Sharifi-Mood B; Davoodikia AA; Moody B; Naghavi A
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1383-7. PubMed ID: 23107636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C(-260)T Polymorphism in CD14 Receptor Gene of Egyptians with Acute Myocardial Infarction.
    Hashad IM; Hossni NM; Abdel Rahman MF; Shehata M; Shaban G; Gad MZ
    Curr Pharm Biotechnol; 2018; 19(4):336-342. PubMed ID: 29874995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.